European Pharmaceutical Review
OCTOBER 12, 2023
September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Meath opened last month.
Express Pharma
JANUARY 17, 2025
By 2028, Lonza aims to ensure that 90 per cent of its spending comes from suppliers with sustainability scores and 67 per cent of Lonzas Scope 3 emissions are covered by suppliers with science-based targets, in alignment with Lonzas validated Scope 3 targets by the Science-Based Targets initiative (SBTi).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
NOVEMBER 24, 2023
These activities are expected to be completed incrementally between 2026 to 2028, the company stated. Recent European manufacturing investments Earlier this month, Novo Nordisk announced that it was planning another manufacturing facility expansion, this time at its site in Kalundborg, Denmark. Construction has already begun.
Express Pharma
MAY 7, 2024
The market for pharmaceutical packaging will grow by 8.24 per cent worldwide and the market for pharmaceutical packaging machines by 7.5 per cent per year until 2028 1. in the EU).
European Pharmaceutical Review
MARCH 25, 2024
The facility is planned to be operational by 2028, Astellas said. Today marks a significant achievement for our company and reflects our continued commitment to expansion and innovation in the region,” declared Hideki Shima, Chief Manufacturing Officer, Astellas Pharma.
Express Pharma
NOVEMBER 24, 2023
lakh crores) by 2028. CPHI & PMEC India, along with its ancillary programmes, spotlights technological strides pivotal in propelling India’s pharma machinery, technology, and ingredients sectors. The Indian pharma industry, on the brink of significant expansion, eyes a projected CAGR of 13 per cent, eyeing a market value of $102.7
Expert insights. Personalized for you.
104 
Let's personalize your content